Evidence map›Paper›PMID 29182619›Full record

ArticlePloS one2017

Response of imported malaria patients to antimalarial medicines in Sri Lanka following malaria elimination.

Priyani Dharmawardena, Chaturaka Rodrigo, Kamini Mendis, W M Kumudu T de A W Gunasekera, Risintha Premaratne, Pascal Ringwald, Deepika Fernando

Abstract read
In one paragraph

Article in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Priyani DharmawardenaAnti Malaria Campaign, Sri Lanka, Narahenpita, Colombo, Sri Lanka.
Chaturaka RodrigoDepartment of Pathology, School of Medical Sciences, University of New South Wales, Sydney, NSW, Australia.
Kamini MendisFormer Coordinator of the Global Malaria Program, World Health Organization, Colombo, Sri Lanka.
W M Kumudu T de A W GunasekeraAnti Malaria Campaign, Sri Lanka, Narahenpita, Colombo, Sri Lanka.
Risintha PremaratneAnti Malaria Campaign, Sri Lanka, Narahenpita, Colombo, Sri Lanka.
Pascal RingwaldWorld Health Organization, Geneva, Switzerland.
Deepika FernandoDepartment of Parasitology, Faculty of Medicine, University of Colombo, Colombo, Sri Lanka.ORCID http://orcid.org/0000-0002-2535-9031

Funding

World Health Organization 001
6 · The paper itself

Abstract

After eliminating local malaria transmission and being certified as a malaria-free country, Sri Lanka is facing the challenge of imported malaria. At the same time, the country has the unique opportunity to be a case study for other countries in a similar situation by approaching this issue systematically, guided by evidence. This study demonstrates the importance of developing a mechanism to detect imported malaria and adopting an evidence-based approach to study the resistance of imported malaria to anti-malarial medicines. This is a prospective study of patients diagnosed with imported malaria in Sri Lanka and treated according to the national treatment guidelines, over 24 months (2015/2016). The clinical features, time to diagnosis, origin of the infection, infecting species, parasite density and the treatment given were recorded. All patients were followed up for 28 days, and in the case of Plasmodium vivax and P. ovale infections, the follow up period was extended to 12 months to establish treatment failures and relapses. Fifty nine uncomplicated and 15 severe imported malaria cases were reported in Sri Lanka during the study period. Most of these infections originated in either Sub-Saharan Africa or South and Southeast Asia. Having a P. vivax infection and low parasitic counts were significantly associated with relative diagnostic delay. One of the 14 uncomplicated P. falciparum patients and two of the 12 severe P. falciparum malaria patients who were followed up till day 28 had a late clinical failure. The others responded adequately to treatment both clinically and parasitologically. There was no treatment failure reported amongst any other species. This study, which is the first to assess the therapeutic response of imported malaria in Sri Lanka after elimination, demonstrates that the current antimalarial treatment policies and strategies in Sri Lanka have been effective against infections acquired overseas up until the end of year 2016.

Indexed as

AdultAntimalarialsFemaleHumansMalariaMaleSri LankaAntimalarials

Identifiers

PMID29182619
PMCPMC5705151

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.